Could Metabolic Therapy Support Cancer Treatment?
Cancer kills so many people across the world everyday but does death have to be such a common outcome?
What If the Foundations of Cancer Research Are Wrong?
Picture an upside-down pyramid and at the base is the starting point of nearly all cancer research. That starting point is that cancer is a genetic disease. From that starting point the vast majority of research then extends and expands upwards.
Yet what if the foundations of that starting point are not solid enough?
What if the initial assumption that cancer is a genetic disease, is wrong?
What if, in fact, part of the story lies one step below, in how the cell makes its energy, and deserves more attention than it gets?
What if the trigger to cancer is not about your genetic makeup?
What if the starting point of cancer is about your metabolic makeup and what does that even mean?
Metabolic: “The total of all chemical changes that take place in a cell to produce energy and basic materials needed for important life processes”.
We are Like Hybrid Cars
Humans are capable of fuelling on two sources of energy: fat and sugar. Many cancer cells rely heavily on glucose and glutamine, and some are less able to use ketones than healthy cells, although some cancers can burn fat. It is for this reason that researchers are interested in a “metabolic therapy” approach as a possible support alongside standard cancer treatment. The idea is that a low carbohydrate, ketogenic diet limits glucose energy to the cancer cells and may weaken them. Some researchers also propose that the stress and inflammation of harsh treatments can raise glucose through the stress pathway, potentially providing further fuel to cancer cells, but this is a hypothesis that has not been proven.
Dr Thomas Seyfried is Professor of Biology at Boston College. He teaches advanced students about cancer metabolism and has worked on metabolic approaches to cancer for 30 years, parallel to research on epilepsy. Ketogenic diets have treated epilepsy since the 1920s, and Seyfried applied similar ideas to cancer. Seyfried notes that death is not generally one of the outcomes of epilepsy and he is strongly of the opinion that death does not have to be one of the outcomes of cancer either, though in way too many cases it is.
Seyfried is helping to develop new, non-toxic metabolic approaches that he hopes could support cancer treatment. These are still being researched, and many doctors and the public at large do not know about them.
For the Past 70 Years We Have Been Told that Cancer is Due to Gene Mutation
Mainstream research sees gene mutations as central to cancer. Inherited genes such as BRCA1 and BRCA2 greatly raise the risk of breast and ovarian cancer, and many modern targeted drugs work by blocking the effects of specific mutations. Seyfried’s position is that these mutations are secondary to metabolic disruption of the cell, which happens first, and he argues that the evidence for this is stronger than mainstream oncology acknowledges. Most mainstream researchers disagree, but the debate continues. In his view genetics will determine which kind of cancer we may be susceptible to, but will not be the cause. Instead, Seyfried argues that cancer starts one step earlier, at the cell fuelling (metabolic stage); disruption of the cells’ respiration whereby energy through oxygen is no longer possible and replaced with the cell making energy through fermentation (through sugar).
Dr Otto Warburg – Nobel Laureate
Seyfried’s work is based on the work of Dr Otto Warburg, the sole recipient of the Nobel Prize for Physiology and Medicine in 1931 (awarded for his discovery of the nature and mode of action of the respiratory enzyme) and originator of the theory of cancer as a metabolic disease. He maintained that cancer starts from damaged respiration of the cells where the cell turns to fermentation of sugar to harness energy without requiring oxygen. This was how cellular energy was harnessed prehistorically (2.5 billion years ago) before the advent of atmospheric oxygen. It is this prehistoric ability to ferment glucose instead of using oxygen for energy that defines the cancer cells. The oxygen however, still enters the cell and although not used for energy will, instead, create ROS (Reactive Oxygen Species: oxygen radicals). It is this that triggers genetic mutations in the cell. So to be clear, Warburg proposed that the genetic mutations you see in cancer are caused by the cell’s inability to use oxygen for energy. This is where his theory has been challenged: later research has shown that many cancer cells do still use oxygen alongside fermenting sugar, and most scientists now see the switch to fermentation as largely driven by the cell’s genetic changes rather than the other way round.
Seyfried’s research has gone a step further and led him to understand that the cancer cells are able to use both glucose and glutamine to survive. (Glutamine will be featured in a future article).
“Locked in System Driven by Dogma and Ideology”
Seyfried’s frustration over the mutilating and toxic characteristics of established cancer treatments is palpable as he believes there is no good enough and explainable reason why this needs to be done. He believes the “locked in system driven by dogma and ideology” is very difficult to change even as early studies suggest a ketogenic approach may be a useful companion to standard treatment, though larger trials are needed. Please never change your cancer treatment without your oncology team. Shouldn’t people at least be told about metabolic approaches that might support their treatment, and be able to discuss them with their oncology team? Chemotherapy and radiotherapy save many lives, but they can also take a toll on the patient’s health in the long term. These treatments can have devastating repercussions to heart health, liver function, etc, etc, the list goes on.
Unfortunately, however, if metabolic therapy is not sanctioned by established medical communities it will not be generally, widely available. Some argue that money plays a part, as there is little financial gain in metabolic (dietary) therapy and so less incentive to fund large studies. The doctors and oncologists will rightly say “show me the studies”, and diet trials in cancer do exist and more are under way, but so far the early results are inconclusive.
It is important to be clear: no trial has shown that diet alone cures cancer. A 2018 study in the Journal of the National Cancer Institute found that patients who chose alternative therapy instead of standard treatment had a much higher risk of death, around two and a half times higher overall. Seyfried would argue that the patients in studies like this were not following a proper metabolic therapy, so he would dispute what they show about his approach. Metabolic therapy should only ever be considered as a possible support alongside standard treatment, never as a replacement.
So Who is Right?
Otto Warburg or the current medical establishment? Perhaps both have part of the answer.
Cancer involves both gene changes and altered metabolism, and many researchers now study how the two interact. Seyfried believes that more attention should be paid to the fuelling of cancer. He also suggests that the stress and inflammation generated by some of the established treatments may cause the body to create more glucose, giving fuel to the cancer cells, though this remains a hypothesis that needs testing.
Like All Things, Prevention Is Better Than Cure
Remember healthy cells can use both fat and sugar for fuel, while many cancer cells rely heavily on glucose and glutamine, although some cancers can burn fat. Raising ketones through a low carb, ketogenic diet where we are metabolically flexible to easily switch between burning fat for fuel instead of simply burning sugar for fuel, in perpetuity, is the first important step. Although we can do a lot, through lifestyle and eating strategies, to limit the cancer cell’s access to glucose, once cancer has developed, glutamine is more problematic to deal with. Drugs targeting glutamine are being researched, and some are being tested at lower doses alongside diet in early studies.
The following protocol is experimental. It has only been studied in small or early research and is not an established treatment. In this approach, the drugs are introduced once the patient has entered ketosis through a carbohydrate restricted diet, eating meat, fish and non-starchy vegetables. Then patients are put on a water only fasting regimen in order to reach therapeutic levels of ketosis, only under close medical supervision. The idea is that at this point the cancer cells are already weakened, which may help non-toxic, low doses of drugs to target glutamine work better. The hope is for drugs that do not cause hair loss, raise your glucose or cause systemic inflammation and impair immunity, but this has yet to be shown in larger trials.
Exercising and Refusing All Cakes
Seyfried believes that patients, in an ideal world, should be told about these metabolic approaches as a possible support to their standard treatment. However, it requires the patient to take responsibility and work hard to adopt habits and regimens that are not necessarily easy. Exercising and refusing all cakes etc! Any change like this should be made together with your oncology team, as part of your treatment rather than instead of it. Though to be fair few are ever even aware that such support exists.
Marina Young, Lymington, England